Astrana Health (ASTH) Stock Forecast & Price Target

$33.70 -1.39 (-3.96%)

(As of 12/20/2024 05:40 PM ET)

Astrana Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 9 Analyst Ratings

Sell
0

Hold
2

Buy
7

Based on 9 Wall Street analysts who have issued ratings for Astrana Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 9 analysts, 2 have given a hold rating, 6 have given a buy rating, and 1 has given a strong buy rating for ASTH.

Consensus Price Target

$65.17
93.37% Upside

According to the 9 analysts' twelve-month price targets for Astrana Health, the average price target is $65.17. The highest price target for ASTH is $86.00, while the lowest price target for ASTH is $50.00. The average price target represents a forecasted upside of 93.37% from the current price of $33.70.

Get the Latest News and Ratings for ASTH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Astrana Health and its competitors.

ASTH Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	N/A
Buy	6 Buy rating(s)	6 Buy rating(s)	4 Buy rating(s)	N/A
Hold	2 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$65.17	$65.17	$59.00	N/A
Forecasted Upside	93.37% Upside	54.75% Upside	3.51% Upside	N/A
Consensus Rating	Moderate Buy	Buy	Buy	N/A

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

ASTH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ASTH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Astrana Health Stock vs. The Competition

Type	Astrana Health	Medical Companies	S&P 500
Consensus Rating Score	2.89	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	93.37% Upside	25,828.59% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent ASTH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/16/2024	Macquarie 1 of 5 stars	T. Qiu Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
11/13/2024	Robert W. Baird 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$67.00 ➝ $86.00	+100.42%
10/14/2024	TD Cowen 5 of 5 stars	R. Langston Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$66.00	+17.38%
10/11/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Gillmor Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Sector Weight
10/3/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$60.00 ➝ $70.00	+20.96%
8/9/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$50.00 ➝ $59.00	+25.93%
8/1/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$48.00 ➝ $60.00	+13.19%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
2/26/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$50.00	+500,000,000.00%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:31 PM ET.

ASTH Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Astrana Health is $65.17, with a high forecast of $86.00 and a low forecast of $50.00.
: 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Astrana Health in the last year. There are currently 2 hold ratings, 6 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ASTH shares.
: According to analysts, Astrana Health's stock has a predicted upside of 93.37% based on their 12-month stock forecasts.
: Over the previous 90 days, Astrana Health's stock had 1 upgrade by analysts.
: Astrana Health has been rated by research analysts at BTIG Research, KeyCorp, Macquarie, Robert W. Baird, and TD Cowen in the past 90 days.
: Analysts like Astrana Health more than other "medical" companies. The consensus rating score for Astrana Health is 2.89 while the average consensus rating score for "medical" companies is 2.81. Learn more on how ASTH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.

This page (NASDAQ:ASTH) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astrana Health (ASTH) Stock Forecast & Price Target